MedPath

Validation of analgesic effect of nitrous oxide in neonates and infants

Not Applicable
Completed
Conditions
eonatal and infant analgesia
Neonatal Diseases
Analgesia
Registration Number
ISRCTN71821503
Lead Sponsor
Department of Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
270
Inclusion Criteria

1. Pre-term newborns (32 - 37 weeks), n = 90
2. Full-term newborns (38 - 42 weeks), n = 90
3. Infants (1 - 3 months), n = 90

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath